Mineralys Therapeutics (MLYS) Free Cash Flow (2022 - 2026)
Quarterly results put Free Cash Flow at -$39.5 million for Q1 2026, up 13.23% from a year ago — trailing twelve months through Mar 2026 was -$136.4 million (up 29.21% YoY), and the annual figure for FY2025 was -$142.4 million, up 14.41%.
Mineralys Therapeutics has reported Free Cash Flow over the past 5 years, most recently at -$39.5 million for Q1 2026.
- Free Cash Flow reached -$39.5 million in Q1 2026 per MLYS's latest filing, down from -$37.9 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$5.5 million in Q2 2022 and bottomed at -$66.8 million in Q4 2024.
- Median Free Cash Flow over the past 5 years was -$28.8 million (2025), compared with a mean of -$27.0 million.
- The largest annual shift saw Free Cash Flow tumbled 272.76% in 2023 before it soared 43.25% in 2025.
- Over 5 years, Free Cash Flow stood at -$10.2 million in 2022, then tumbled by 184.52% to -$29.0 million in 2023, then plummeted by 130.64% to -$66.8 million in 2024, then skyrocketed by 43.25% to -$37.9 million in 2025, then dropped by 4.06% to -$39.5 million in 2026.
- Business Quant data shows Free Cash Flow for MLYS at -$39.5 million in Q1 2026, -$37.9 million in Q4 2025, and -$28.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 848.30 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | -39.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.47 Mn |
| Mar 31, 2026 | -39.47 Mn |
| Dec 31, 2025 | -37.93 Mn |
| Dec 31, 2025 | -37.93 Mn |
| Sep 30, 2025 | -28.80 Mn |
| Sep 30, 2025 | -28.80 Mn |
| Jun 30, 2025 | -30.21 Mn |
| Jun 30, 2025 | -30.21 Mn |
| Mar 31, 2025 | -45.49 Mn |
| Mar 31, 2025 | -45.49 Mn |
| Dec 31, 2024 | -66.84 Mn |
| Dec 31, 2024 | -66.84 Mn |
| Sep 30, 2024 | -50.22 Mn |
| Sep 30, 2024 | -50.22 Mn |
| Jun 30, 2024 | -30.15 Mn |
| Jun 30, 2024 | -30.15 Mn |
| Mar 31, 2024 | -19.20 Mn |
| Mar 31, 2024 | -19.20 Mn |
| Dec 31, 2023 | -28.98 Mn |
| Dec 31, 2023 | -28.98 Mn |
| Sep 30, 2023 | -19.03 Mn |
| Sep 30, 2023 | -19.03 Mn |
| Jun 30, 2023 | -20.39 Mn |
| Jun 30, 2023 | -20.39 Mn |
| Mar 31, 2023 | -12.78 Mn |
| Mar 31, 2023 | -12.78 Mn |
| Dec 31, 2022 | -10.19 Mn |
| Dec 31, 2022 | -10.19 Mn |
| Sep 30, 2022 | -6.99 Mn |
| Sep 30, 2022 | -6.99 Mn |
| Jun 30, 2022 | -5.47 Mn |
| Jun 30, 2022 | -5.47 Mn |
| Mar 31, 2022 | -6.58 Mn |
| Mar 31, 2022 | -6.58 Mn |